(RTTNews) - AVITA Medical, Inc. (RCEL), a regenerative medicine company focused on innovative wound care solutions, announced that the U.S. Food and Drug Administration has approved its premarket ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback